作者: 值得贊賞 時(shí)間: 2025-3-21 22:25 作者: 死亡率 時(shí)間: 2025-3-22 02:21 作者: Medley 時(shí)間: 2025-3-22 06:15
https://doi.org/10.1007/978-3-322-88975-1hological features, highlights the role of immunohistochemistry and molecular studies in distinguishing desmoids from potential mimics, and briefly discusses the clinical behavior with reference to possible predictors of recurrence.作者: 消息靈通 時(shí)間: 2025-3-22 09:02 作者: Decimate 時(shí)間: 2025-3-22 13:24
Gabler Wirtschaftsw?rterbuch Russisch for desmoid tumors, but also to shed light into fundamental aspects of tumor biology that will have broad ranging applications. Its classification as a benign process could have implications hampering research, advocacy, and management progress.作者: Decimate 時(shí)間: 2025-3-22 17:52 作者: 不溶解 時(shí)間: 2025-3-22 22:30 作者: insightful 時(shí)間: 2025-3-23 04:05 作者: BADGE 時(shí)間: 2025-3-23 06:46 作者: SPASM 時(shí)間: 2025-3-23 12:28
Gabler Wirtschaftsw?rterbuch Russischeatment of a child with desmoid tumor may present unique problems. In this chapter, we review the pathology, biology, clinical presentation, and treatment of children with desmoid tumor as we highlight the similarities and differences from desmoid tumor in adults.作者: 態(tài)度暖昧 時(shí)間: 2025-3-23 16:42 作者: reserve 時(shí)間: 2025-3-23 19:49
Interventional Radiologyve recurred after surgery, radiation, and/or chemotherapy, and as a palliative option for patients with unresectable lesions. In this chapter, the mechanism of action and rationale for use, as well as technical and clinical considerations of each technique will be discussed.作者: gangrene 時(shí)間: 2025-3-24 01:46 作者: SPECT 時(shí)間: 2025-3-24 04:38
Gabler Wirtschaftsw?rterbuch Russischric obstruction. No treatment is predictably effective but options include nonsteroidal antiinflammatory drugs (NSAIDs), antiestrogen drugs, chemotherapy, and excision. While desmoid disease can be lethal, patients usually live in equilibrium with their disease.作者: Synapse 時(shí)間: 2025-3-24 06:49 作者: LIMN 時(shí)間: 2025-3-24 12:16 作者: 不要嚴(yán)酷 時(shí)間: 2025-3-24 16:29
The Role of Patient Advocacy Groups in Rare Tumors Such as Desmoid Tumorsy harnessing modern web-based and other communication technologies, these advocacy groups link patients, patrons, medical practitioners and researchers to address the unique problems facing small patient population diseases. This article is a guide to these groups and examines their efforts and results.作者: Inflamed 時(shí)間: 2025-3-24 22:42 作者: 轉(zhuǎn)換 時(shí)間: 2025-3-25 01:20
https://doi.org/10.1007/978-3-322-88975-1sually straightforward but can be difficult in small biopsies and in recurrences associated with scars from a prior procedure. Immunohistochemistry, specifically β-catenin, and more recently, molecular diagnostics can play an important role in its diagnosis. This chapter reviews the clinical and pat作者: Flawless 時(shí)間: 2025-3-25 06:15 作者: 蟄伏 時(shí)間: 2025-3-25 09:02 作者: 數(shù)量 時(shí)間: 2025-3-25 13:35 作者: 史前 時(shí)間: 2025-3-25 19:42 作者: 闡釋 時(shí)間: 2025-3-25 20:37
Gabler Wirtschaftsw?rterbuch Russischames Ewing was the first to report the successful use of radiotherapy in the management of unresectable desmoid tumors in 1928 [1]. Since then several studies have shown excellent control rates with radiation, which indicate a role for radiotherapy in the multidisciplinary management of these nonmal作者: pulmonary 時(shí)間: 2025-3-26 03:07
https://doi.org/10.1007/978-3-322-88975-1 alternative therapies which maximize efficacy and minimize patient morbidity. Interventional radiology and interventional oncology offer several minimally invasive, percutaneous image-guided procedures that are well suited to the challenges that desmoid tumors present. Fine needle aspiration and co作者: insular 時(shí)間: 2025-3-26 07:42
Gabler Wirtschaftsw?rterbuch Russischthe tumor suppressor gene .. About 30% of patients with familial adenomatous polyposis develop desmoid disease, especially women, those with a family history of desmoids, those with the extracolonic manifestations of Gardner’s syndrome, and those with a mutation 3′ of codon 1440. Most desmoids occur作者: obscurity 時(shí)間: 2025-3-26 11:41
Gabler Wirtschaftsw?rterbuch Russischwn to have a locally invasive growth that can lead to severe and sometimes life-threatening problems. The historical standards of therapy for desmoid tumor center on surgical resection, with or without radiation therapy. However, depending on the site or size of the disease, surgical resection may s作者: Antioxidant 時(shí)間: 2025-3-26 13:35 作者: persistence 時(shí)間: 2025-3-26 18:13
Gabler Wirtschaftsw?rterbuch Russischstasize and as such are classified as benign lesions, their clinical behavior, cellular biology, and molecular etiology all share more characteristics with malignancies than benign processes. Research into these aspects of desmoid tumor biology has the potential not only to develop better treatments作者: 特別容易碎 時(shí)間: 2025-3-26 21:14 作者: 消毒 時(shí)間: 2025-3-27 04:59
Charisse LitchmanFirst manuscript on desmoid tumors.World renowned authors.Encompasses topics of relevance to clinicians, scientific researchers and advocacy groups.Provides concrete guidance for treatment planning.Ad作者: Aura231 時(shí)間: 2025-3-27 06:36 作者: Carcinogen 時(shí)間: 2025-3-27 13:02 作者: 圖表證明 時(shí)間: 2025-3-27 16:27 作者: 即席演說(shuō) 時(shí)間: 2025-3-27 20:42
Gabler Wirtschaftsw?rterbuch Russischor these neoplasms. The APC/β-catenin pathway is known to be deregulated in DT. This chapter illuminates the molecular mechanisms of APC/β-catenin pathway signaling, elucidates the potential deregulations and mutations at play in DTs, and most importantly evaluates the possible implications of this pathway on DT diagnosis, prognosis, and therapy.作者: 疏忽 時(shí)間: 2025-3-27 22:29 作者: 只有 時(shí)間: 2025-3-28 03:04
Clinical Presentation of Desmoid Tumorsh as Familial Adenomatous Polyposis (FAP). Despite the absence of metastatic potential, DT may cause debilitating symptoms and in some cases life-threatening organ damage because of their locally invasive nature. DT may range from small slow-growing masses to rapidly enlarging aggressive tumors. The作者: 季雨 時(shí)間: 2025-3-28 09:20
Pathology of Desmoid Tumorssually straightforward but can be difficult in small biopsies and in recurrences associated with scars from a prior procedure. Immunohistochemistry, specifically β-catenin, and more recently, molecular diagnostics can play an important role in its diagnosis. This chapter reviews the clinical and pat作者: eardrum 時(shí)間: 2025-3-28 12:39
APC/β-Catenin Deregulation in Desmoid Tumors: Important Implications for Diagnosis, Prognosis, and Tor these neoplasms. The APC/β-catenin pathway is known to be deregulated in DT. This chapter illuminates the molecular mechanisms of APC/β-catenin pathway signaling, elucidates the potential deregulations and mutations at play in DTs, and most importantly evaluates the possible implications of this 作者: 大喘氣 時(shí)間: 2025-3-28 17:01 作者: abject 時(shí)間: 2025-3-28 21:25
Surgical Management of Desmoid Tumors tumors. Moreover, their diverse anatomic location, propensity for recurrence, and unpredictable biologic behavior present unique challenges for surgeons and other physicians involved in their management. A well-coordinated, multidisciplinary approach involving the input of surgical and nonsurgical 作者: anagen 時(shí)間: 2025-3-29 01:26 作者: 劇本 時(shí)間: 2025-3-29 05:42
Radiation Therapy for Desmoid Tumorsames Ewing was the first to report the successful use of radiotherapy in the management of unresectable desmoid tumors in 1928 [1]. Since then several studies have shown excellent control rates with radiation, which indicate a role for radiotherapy in the multidisciplinary management of these nonmal作者: 健忘癥 時(shí)間: 2025-3-29 09:01
Interventional Radiology alternative therapies which maximize efficacy and minimize patient morbidity. Interventional radiology and interventional oncology offer several minimally invasive, percutaneous image-guided procedures that are well suited to the challenges that desmoid tumors present. Fine needle aspiration and co作者: 教育學(xué) 時(shí)間: 2025-3-29 14:05 作者: 支形吊燈 時(shí)間: 2025-3-29 18:19 作者: Wernickes-area 時(shí)間: 2025-3-29 23:45 作者: 激怒 時(shí)間: 2025-3-30 03:41 作者: LAVA 時(shí)間: 2025-3-30 05:12
